BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36463105)

  • 1. Carbapenem resistance gene crisis in A. baumannii: a computational analysis.
    Zahra N; Zeshan B; Ishaq M
    BMC Microbiol; 2022 Dec; 22(1):290. PubMed ID: 36463105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular docking and dynamic approach to screen the drug candidate against the Imipenem-resistant CarO porin in Acinetobacter baumannii.
    Gopikrishnan M; George Priya Doss C
    Microb Pathog; 2023 Apr; 177():106049. PubMed ID: 36858184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Based on molecular docking and real-time PCR technology, the two-component system Bae SR was investigated on the mechanism of drug resistance in CRAB.
    Pan B; Wang Y; Su J; Liu Y; Yang J; Zhou Y; Sun L
    BMC Microbiol; 2024 Apr; 24(1):126. PubMed ID: 38622558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictability of doripenem susceptibility in Acinetobacter baumannii isolates based on other carbapenem susceptibilities and bla OXA gene status.
    Esterly JS; Qi C; Malczynski M; Scheetz MH
    Pharmacotherapy; 2010 Apr; 30(4):354-60. PubMed ID: 20334455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbapenem susceptibility testing errors using three automated systems, disk diffusion, Etest, and broth microdilution and carbapenem resistance genes in isolates of Acinetobacter baumannii-calcoaceticus complex.
    Markelz AE; Mende K; Murray CK; Yu X; Zera WC; Hospenthal DR; Beckius ML; Calvano T; Akers KS
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4707-11. PubMed ID: 21807971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of carbapenem-hydrolyzing OXA-type β-lactamases among Acinetobacter baumannii in patients with severe urinary tract infection.
    Girija SA; Priyadharsini JV; Paramasivam A
    Acta Microbiol Immunol Hung; 2019 Dec; 67(1):49-55. PubMed ID: 31813258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal survey of carbapenem resistance and resistance mechanisms in Enterobacteriaceae and non-fermenters from the USA in 2007-09.
    Davies TA; Marie Queenan A; Morrow BJ; Shang W; Amsler K; He W; Lynch AS; Pillar C; Flamm RK
    J Antimicrob Chemother; 2011 Oct; 66(10):2298-307. PubMed ID: 21775338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular docking, dynamics and free energy analyses of
    Ramachandran B; Jeyakanthan J; Lopes BS
    J Med Microbiol; 2020 Aug; 69(8):1062-1078. PubMed ID: 32773005
    [No Abstract]   [Full Text] [Related]  

  • 9. Association of doripenem resistance with OXA-type carbapenemases in Acinetobacter baumannii isolates.
    Terzi HA; Atasoy AR; Aykan SB; Karakece E; Asık G; Ciftci IH
    Saudi Med J; 2016 Jan; 37(1):43-7. PubMed ID: 26739973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of doripenem against Acinetobacter baumannii clinical isolates.
    Marti S; Sánchez-Céspedes J; Alba V; Vila J
    Int J Antimicrob Agents; 2009 Feb; 33(2):181-2. PubMed ID: 18977642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Distribution of blaOXA genes in Acinetobacter baumannii strains: a multicenter study].
    Ciftci IH; Aşık G; Karakeçe E; Oksüz L; Yağcı S; Sesli Çetin E; Ozdemir M; Atasoy AR; Koçoğlu E; Gül M; Kurtoğlu MG; Köksal Çakırlar F; Seyrek A; Berktaş M; Gültepe B; Ayyildiz A
    Mikrobiyol Bul; 2013 Oct; 47(4):592-602. PubMed ID: 24237428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro activity of carbapenems against clinical isolates of Acinetobacter baumannii.
    Douraghi M; Ghalavand Z; Nateghi Rostami M; Zeraati H; Aliramezani A; Rahbar M; Mohammadzadeh M; Ghourchian S; Boroumand MA; Abdollahi A
    J Appl Microbiol; 2016 Aug; 121(2):401-7. PubMed ID: 27171885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbapenem-resistant Acinetobacter baumannii: Current status of the problem in four Bulgarian university hospitals (2014-2016).
    Strateva T; Sirakov I; Stoeva T; Stratev A; Dimov S; Savov E; Mitov I
    J Glob Antimicrob Resist; 2019 Mar; 16():266-273. PubMed ID: 30412782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the pharmacodynamic profile of intravenous antibiotics against prevalent Gram-negative organisms collected in Colombia.
    Villegas MV; Briceno DF; Ruiz SJ; Furtado GH; Nicolau DP
    Braz J Infect Dis; 2011; 15(5):413-9. PubMed ID: 22230846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization and antibiotic resistance of Acinetobacter baumannii in cerebrospinal fluid and blood.
    Shi X; Wang H; Wang X; Jing H; Duan R; Qin S; Lv D; Fan Y; Huang Z; Stirling K; Zhang L; Wang J
    PLoS One; 2021; 16(2):e0247418. PubMed ID: 33617547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the Hydrophobic Bridge in the Carbapenemase Activity of Class D β-Lactamases.
    Stewart NK; Smith CA; Antunes NT; Toth M; Vakulenko SB
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30530607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insertion sequences and sequence types profile of clinical isolates of carbapenem-resistant A. baumannii collected across India over four year period.
    Vijayakumar S; Anandan S; Ms DP; Kanthan K; Vijayabaskar S; Kapil A; Ray P; Sistla S; Bhattacharya S; Wattal C; Thirunarayan ; Deotale V; Mathur P; Walia K; Ohri VC; Veeraraghavan B
    J Infect Public Health; 2020 Jul; 13(7):1022-1028. PubMed ID: 31874816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates].
    Turk Dagi H; Kus H; Arslan U; Tuncer I
    Mikrobiyol Bul; 2014 Apr; 48(2):311-5. PubMed ID: 24819268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of in vitro activity of doripenem, imipenem and meropenem against clinical isolates of Enterobacteriaceae, Pseudomonas and Acinetobacter in Southern Poland.
    Drzewiecki A; Bulanda M; Talaga K; Sodo A; Adamski P
    Pol Przegl Chir; 2012 Sep; 84(9):449-53. PubMed ID: 23241660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative pharmacodynamics of four different carbapenems in combination with polymyxin B against carbapenem-resistant Acinetobacter baumannii.
    Lenhard JR; Gall JS; Bulitta JB; Thamlikitkul V; Landersdorfer CB; Forrest A; Nation RL; Li J; Tsuji BT
    Int J Antimicrob Agents; 2016 Dec; 48(6):719-724. PubMed ID: 27773498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.